Armata Pharmaceuticals ARMP
NYSE ARMP
$3.43 +0.37 (+12.09%)
As of: Oct 22, 2026 · 3:59 PM EDT

Armata Pharmaceuticals (ARMP) Long-Term Debt Repayments (2017)

Updated

Armata Pharmaceuticals (ARMP) posted Long-Term Debt Repayments of $305,000 for Q3 2017.

Analysis

Armata Pharmaceuticals (ARMP) Long-Term Debt Repayments (2017) Analysis & Trends

For the trailing twelve months through Sep 30, 2017, Long-Term Debt Repayments at Armata Pharmaceuticals was $510,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 873.00 Mn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 1.00 Mn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 2.00 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 5.00 Mn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 20.00 Mn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 2.46 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 17.00 Mn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Armata Pharmaceuticals 126.41 Mn 74.12 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2017 305,000.00
Mar 31, 2017 205,000.00
API Access

Armata Pharmaceuticals Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=ARMP&period=max&api_key=YOUR_API_KEY